Your browser doesn't support javascript.
loading
Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors--the first molecular targeted treatment.
Bumbea, Horia; Vladareanu, Ana-Maria; Voican, Irina; Cisleanu, Diana; Barsan, Lavinia; Onisai, Minodora.
Affiliation
  • Bumbea H; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
J Med Life ; 3(2): 162-6, 2010.
Article in En | MEDLINE | ID: mdl-20968202
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Med Life Journal subject: MEDICINA Year: 2010 Document type: Article Affiliation country: Romania Country of publication: Romania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Med Life Journal subject: MEDICINA Year: 2010 Document type: Article Affiliation country: Romania Country of publication: Romania